Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, Poland.
Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, Poland.
Obes Res Clin Pract. 2018 May-Jun;12(3):251-259. doi: 10.1016/j.orcp.2018.01.005. Epub 2018 Feb 7.
Obesity, characterised as a chronic low-grade inflammation is a crucial risk factor for colon cancer. The expansion of the adipose tissue is related to elevated triglyceride and low-density lipoprotein (LDL) levels and hyperinsulinemia, which all are presumed mediators of the tumour development. Obesity is also believed to support carcinogenesis by activating the insulin/IGF-1 pathway. Moreover, obesity increases the level of proinflammatory cytokines (e.g. TNF-α, IL-1, and IL-6) and has a significant impact on selected adipokines. This paper briefly outlines the latest evidence of the linkage between the obesity and colon cancer and discusses its possible implication for the improvement of anticancer prevention and treatment strategies connected with nutrition.
肥胖是一种慢性低度炎症,是结肠癌的一个关键危险因素。脂肪组织的扩张与甘油三酯和低密度脂蛋白(LDL)水平升高以及高胰岛素血症有关,所有这些都被认为是肿瘤发展的介质。肥胖还通过激活胰岛素/IGF-1 途径来支持致癌作用。此外,肥胖会增加促炎细胞因子(例如 TNF-α、IL-1 和 IL-6)的水平,并对选定的脂肪因子产生重大影响。本文简要概述了肥胖与结肠癌之间联系的最新证据,并讨论了其对改善与营养相关的抗癌预防和治疗策略的可能意义。